Skip to search formSkip to main contentSkip to account menu

Tagrisso

National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

osimertinibosimertinib mesylate
osimertinib 40 MG Oral Tablet [Tagrisso]osimertinib Oral Tablet [Tagrisso]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Osimertinib (TAGRISSO™) and the cobas® EGFR Mutation Test v2
2018
2018
Tagrisso (osimertinib) v léčbě NSCLC - kazuistiky dvou pacientů
2017
2017
話題のクスリ 129 抗悪性腫瘍剤/チロシンキナーゼ阻害剤 タグリッソ錠40mg・80mg TAGRISSO Tablets(オシメルチニブメシル酸塩錠)
2016
2016
Tagrisso (Osimertinib) Approved for Patients with Non–Small-Cell Lung Cancer and the EGFR T790M Mutation
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)